- Localization of Seegene Syndromic PCR technologies with global partners for versatile and proactive response to local emerging healthcare demands. - Formation of a collaborative global network to aggressively develop innovative syndromic PCR assays, challenging boundaries of PCR application. - Affordable and accessible syndromic PCR tests to the public through...
- Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene’s technology-sharing initiative - The two companies will co-establish a NewCo in Spain to serve as a strategic hub in Europe, accelerating global expansion of the initiative - Localization...
* Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology * Companies will facilitate C-level cooperation, strengthening the partnership for the SG OneSystem™ business (Seegene’s technology-sharing business) Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR...
• The first tri-party executive roundtable was held in London to strengthen synergies for Seegene’s vision of creating ‘a world free from diseases’ • Preliminary results of product development automation and statistical analysis of syndromic test results powered with Microsoft’s AI technology were showcased • Global experts and scientists participated in...